Lifitegrast Terminated Phase 1 Trials for Diabetic Macular Edema (DME) / Pars Plana Vitrectomy Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00936520SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy